Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Oracle Faces Scrutiny as Analyst Questions Cloud Business Model

Robert Sasse by Robert Sasse
October 1, 2025
in AI & Quantum Computing, Analysis, Tech & Software
0
Oracle Stock
0
SHARES
92
VIEWS
Share on FacebookShare on Twitter

Oracle finds itself at a critical juncture as conflicting narratives emerge about its true position in the cloud computing sector. While the technology giant continues to announce massive AI commitments and record cloud contract growth, a fundamental question is being raised by financial analysts: Is Oracle genuinely a cloud provider, or merely an expensive financing partner with inflated valuations?

The controversy gained significant traction in late September when investment bank Rothschild & Co’s research arm, Redburn, issued a stark “Sell” rating for Oracle shares. The firm set a price target of just $175, representing a nearly 40 percent discount to the stock’s current trading levels. This bearish assessment directly challenges the prevailing market optimism surrounding Oracle’s cloud ambitions.

Questioning the Core Business Model

At the heart of the skepticism lies Rothschild’s characterization of Oracle’s approach to large single-tenant deployments. The analysis suggests the company operates “more like a financier than a cloud provider,” with an economic model that “differs significantly from the approach investors typically value.” This fundamental challenge to Oracle’s cloud identity comes during what should be a triumphant period for the company.

Just as these doubts emerged, Oracle had revealed extraordinary growth in its remaining performance obligations, which surged 359 percent to $455 billion. This massive increase was primarily fueled by multibillion-dollar cloud agreements, including a reported $300 billion arrangement with OpenAI. Following this announcement, Oracle’s stock had climbed more than 30 percent, reflecting strong market enthusiasm.

Should investors sell immediately? Or is it worth buying Oracle?

The $60 Billion Guidance Under Microscope

Market experts are expressing particular concern about Oracle’s five-year cloud revenue guidance of approximately $60 billion. According to skeptical analysts, these ambitious targets appear fully priced into the current stock valuation and represent a “high-risk dream scenario that will likely fail to materialize.” The timing of this scrutiny is notable, given Oracle’s recent bond issuance of $18 billion in late September—one of the largest corporate debt offerings this year—to fund its aggressive AI infrastructure expansion.

The company’s internal projections outline dramatic growth targets for Oracle Cloud Infrastructure: reaching $18 billion by 2026 (a 77 percent increase), followed by progressively ambitious targets of $32 billion, $73 billion, $114 billion, and ultimately $144 billion in subsequent years. These very projections now face intense examination from financial researchers.

Balancing AI Enthusiasm with Financial Reality

Oracle currently navigates the complex territory between artificial intelligence euphoria and economic fundamentals. The company receives praise for its involvement with TikTok U.S. operations and partnerships with AI pioneers, yet warning voices about potential overvaluation are growing louder.

With a market capitalization exceeding $800 billion, Oracle now ranks among the ten most valuable U.S. companies. Its shares have advanced approximately 70 percent since the beginning of the year, though the stock has experienced volatility between $280 and $285 since reaching its September peak. This price fluctuation reflects the ongoing tension between Oracle’s promising AI positioning and emerging questions about its underlying business economics.

Ad

Oracle Stock: Buy or Sell?! New Oracle Analysis from March 25 delivers the answer:

The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Oracle: Buy or sell? Read more here...

Tags: Oracle
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock
Analysis

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock
AI & Quantum Computing

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
Next Post
MSCI World ETF Stock

The AI Investment Wave: How Global Equity ETFs Are Capitalizing on Technological Transformation

QuantumScape Stock

QuantumScape Shares Surge on Key Manufacturing Partnership

Oxford Lane Capital Stock

Oxford Lane Capital Navigates Major Overhaul Amid Market Pressure

Recommended

Alphabet Stock

Alphabet Shares Face Regulatory Headwinds Despite Autonomous Driving Breakthrough

4 months ago
Dish Network Stock

Institutional Investors Show Diverging Views on Dish Network’s Future

7 months ago
Finance_ Trading ratings today (2)

Lakeland Financial Exceeds Expectations with Fourth Quarter Earnings

2 years ago
DeFi Technologies Stock

DeFi Technologies: Navigating Expansion Amidst Legal Headwinds

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Trending

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

by Kennethcix
March 25, 2026
0

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational...

Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds
  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com